[54] in women with PCOS, BMI 25 kg/m 2 and/or insulin resistance, treatment with liraglutide 1.8 mg/day for 26 weeks, along with a higher weight loss, induced significant reductions in fasting plasma glucose, HbA1c, and plasma glucose AUC, whereas Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), Matsuda index and insulin AUC remained unchanged
Several studies have reported similar findings about the ability of serum concentrations of LC, short-chain, medium-chain, and long-chain ACs to differentiate patients with HCC from those with liver disease or healthy controls
News provided by Supergut Jun 17, 2025, 08:43 ET The clinically-backed formula is now available in summer flavors to support gut-health
Metabolism and nutrition disorders: hypokalemia